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Summary
Objective: To test the hypothesis that terminal differentiation of chondrocytes in human osteoarthritic cartilage might lead to the failure of
repair mechanisms and might cause progressive loss of structure and function of articular cartilage.
Design: Markers for terminally differentiated chondrocytes, such as alkaline phosphatase, annexin II, annexin V and type X collagen, were
detected by immunohistochemical analysis of human normal and osteoarthritic knee cartilage from medial and lateral femoral condyles.
Apoptosis in these specimens was detected using the TUNEL labeling. Mineralization and matrix vesicles were detected by alizarin red S
staining and electron microscopic analysis.
Results: Alkaline phosphatase, annexin II, annexin V and type X collagen were expressed by chondrocytes in the upper zone of early stage
and late stage human osteoarthritic cartilage. However, these proteins, which are typically expressed in hypertrophic and calcifying growth
plate cartilage, were not detectable in the upper, middle and deep zones of healthy human articular cartilage. TUNEL labeling of normal and
osteoarthritic human cartilage sections provided evidence that chondrocytes in the upper zone of late stage osteoarthritic cartilage undergo
apoptotic changes. In addition, mineral deposits were detected in the upper zone of late stage osteoarthritic cartilage. Needle-like mineral
crystals were often associated with matrix vesicles in these areas, as seen in calcifying growth plate cartilage.
Conclusion: Human osteoarthritic chondrocytes adjacent to the joint space undergo terminal differentiation, release alkaline phosphatase-,
annexin II- and annexin V-containing matrix vesicles, which initiate mineral formation, and eventually die by apoptosis. Thus, these cells
resume phenotypic changes similar to terminal differentiation of chondrocytes in growth plate cartilage culminating in the destruction of
articular cartilage in osteoarthritis. © 2000 OsteoArthritis Research Society International
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Synovial joints allow the movement of skeletal elements,
such as those in the limbs, vertebral column and mandible.
Normal joint function throughout life is largely dependent on
the structural and functional integrity of articular cartilage
and the phenotypic stability of articular chondrocytes,
the cells that produce, maintain, remodel and repair the
extracellular matrix of articular cartilage.
During endochondral ossification chondrocytes undergo
a series of differentiation events, including proliferation,
hypertrophy, terminal differentiation and eventually cell
death (apoptosis). In addition, terminally differentiated
chondrocytes release matrix vesicles, alkaline phos-
phatase, annexin II and annexin V-containing particles
which initiate mineralization of the extracellular matrix.1–4294In contrast, chondrocytes in healthy human articular
cartilage maintain a stable phenotype. These cells do not
proliferate but are capable of producing matrix com-
ponents, such as type II, IX, XI collagen and aggrecan.
Articular cartilage can be divided into four zones (upper,
middle, deep, and calcified zone). Each zone has a differ-
ent composition and structure depending on the different
functional demands of these zones in articular cartilage.5,6
For example, the collagen fibrils in the upper zone are
thinner and the amount of aggrecan is lower than in the
deeper zones. In addition, cells and collagen fibrils in the
upper layer are arranged differently to those in the deeper
layers.5,6 The zone of calcified cartilage, the deepest zone
of articular cartilage, provides a smooth transition from the
noncalcified articular cartilage matrix to the highly calcified
underlying bone matrix.7 Chondrocytes in calcified articular
cartilage, in contrast to cells in noncalcified articular carti-
lage, retain some properties of hypertrophic growth plate
chondrocytes and synthesize hypertrophic marker proteins,
such as alkaline phosphatase and type X collagen.8,9
Degenerative joint diseases, such as osteoarthritis, are
characterized by an initial loss of proteoglycans from the
upper zone followed by the degradation of the collagen
network.10,11 Several studies have provided evidence that
synthesis of types II, VI, IX, XI collagen is significantlyReceived 24 August 1999; accepted 25 December 1999.
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healthy articular cartilage, suggesting that articular
chondrocytes try to repair the damaged matrix.12–16 How-
ever, eventually the reparative processes fail and the
breakdown of the cartilage matrix leads to a progressive
loss of the various zones of articular cartilage. In addition,
some studies have shown a switch in collagen synthesis to
types I and III collagen in osteoarthritic cartilage, suggest-
ing a ‘dedifferentiation’ of articular chondrocytes.17–19 On
the other hand, expression of type X collagen and annexin
V has been demonstrated in human osteoarthritic cartilage,
which would be indicative for chondrocyte hypertrophy as a
further differentiation.9,20–23 Apart from these findings, it
has been demonstrated that chondrocytes in osteoarthritic
cartilage upregulate the synthesis of proteolytic enzymes,
suggesting that the loss of matrix in osteoarthritic cartilage
reflects the action of these proteolytic enzymes.24–27 How-
ever, the exact mechanisms which lead to a failure of
the reparative processes, degradation of the extra-
cellular matrix and loss of cartilage integrity, are not well
understood.
In this study we investigated the hypothesis that
chondrocytes in the upper zone of human osteoarthritic
cartilage undergo phenotypic changes, resulting in a pro-
gressive loss of articular cartilage structure and function.
Using immunohistochemistry and electron microscopy we
investigated whether chondrocytes of human osteoarthritic
cartilage undergo terminal differentiation which might be a
cause of progressive cartilage breakdown.
Methods
TISSUE SAMPLES
Human osteoarthritic knee cartilage from medial and
lateral femoral condyles (56–85 year old donors) was
collected from patients undergoing knee arthoplasty (14
samples) at the time of surgery. Clinical data of these
patients were carefully reviewed to exclude secondary
forms of OA, such as rheumatoid arthritis. Articular carti-
lage without signs of OA was obtained from human knees
(34–59 year old donors, four samples) within 12–24 h after
death. Sections from all cartilage specimens were stained
with hematoxylin and safrain O staining to determine the
severity of OA.28 Based on histology the specimens were
classified into early (no signs of fibrillation, some clustering
of cells evident, overall thickness of cartilage preserved)
and late (extensive fissuring and fibrillation, clustering of
chondrocytes, loss of cartilage) forms of OA. This study
included samples of original articular cartilage only, and
excluded osteophytes and other repair cartilage. In
addition, only areas of late stage osteoarthritic cartilage
are shown in this study which show a largely preserved
cartilage thickness.
The localization of annexin II and annexin V was also
studied in 19-day-old chick growth plate cartilage.
IMMUNOHISTOLOGY
Human articular cartilage samples with underlying
bone were fixed with 4% paraformaldehyde in phosphate
buffered saline for 24 h and then decalcified using 0.2 M
EDTA (pH 8.0) at 4°C for several weeks. Samples were
embedded in paraffin and 5 m thick sections were cut
perpendicular to the cartilage surface. Before immuno-
staining, sections were treated with sheep testicularhyaluronidase (2 mg/ml; Sigma Chemicals Co., St Louis,
MO) for 30 min at 37°C. Immunostaining was performed
using the HistostainY SP Kit (Zymed Laboratories Inc., San
Francisco, CA) following the manufacturer’s instructions.
Briefly, sections were treated with peroxidase quenching
solution to eliminate endogenous peroxidase activity, fol-
lowed by incubation with a blocking solution for 10 min
at room temperature. Sections were then incubated with
primary antibodies for 3 h at room temperature followed
by biotinylated secondary antibodies for 10 min at room
temperature. After washing, sections were incubated with
a streptavidin–peroxidase conjugate for 10 min at room
temperature followed by a solution containing diamino-
benzidine (DAB; chromogen) and 0.03% hydrogen
peroxide for 5 min at room temperature. Sections were
counterstained with hematoxylin, dehydrated, mounted and
viewed under a Zeiss microscope.
To localize calcium deposits, nondecalcified sections
were stained with 0.5% alizarin red S solution, pH 4.0, for
5 min at room temperature. Stained sections were washed
three times with water and ethanol.
END LABELING OF TISSUE SECTIONS USING A TERMINAL
DEOXYNUCLEOTIDYL TRANSFERASE (TUNEL PROCEDURE)
End labeling of human cartilage sections was performed
using TACS 2 TdT In Situ Apoptosis Detection Kit
(Trevigen, Inc., Gaithersburg, MD). Sections were first
treated with 1% Triton X-100 in phosphate buffered saline
(pH 7.4) for 10 min at room temperature followed by
treatment with proteinase K (20 g/ml) for 15 min at room
temperature and, to inhibit peroxidase activity, by incu-
bation with 3% H2O2 in phosphate buffered saline for 5 min
at room temperature. Prior to labeling, sections were
equilibrated in a transferase labeling buffer for 5 min and
then incubated in a reaction mixture containing bio-
tin-labeled deoxynucleotides, Mn2+ and terminal deoxy-
nucleotidyl transferase at 37°C. After 60 min the incubation
was stopped and the nucleotides were detected using
streptavidin-conjugated peroxidase and DAB as a color
substrate. Sections were counterstained with methylen
green, mounted and viewed under a Zeiss microscope.
SEMI-QUANTITATIVE ANALYSIS OF CHONDROCYTES SHOWING
CELL-ASSOCIATED IMMUNOSTAINING OR TUNEL-LABELING
To gain some insight into the extent of expression of
terminal differentiation marker proteins or apoptosis in
osteoarthritic cartilage, the percentage of stained cells in
osteoarthritic cartilage was determined. We counted 200–
300 chondrocytes in each zone (upper, middle, deep,
calcified) of separately stained sections from different
donors (four normal articular cartilage samples, four early
stage and five late stage osteoarthritic cartilage samples).
Data are expressed as the mean±SD of the percentage of
total cells which show cell-associated staining. For apopto-
sis, TUNEL-positive single cells and cells in clusters were
counted separately.
ELECTRON MICROSCOPY
Tissue was fixed in 2.5% glutaraldehyde in 0.1 M sodium
cacodylate (pH 7.4) containing 2% tannin and post-fixed in
1% osmium tetroxide. The tissues were dehydrated in a
296 T. Kirsch et al.: Terminal differentiation in osteoarthritisgraded series of ethanol and embedded in epoxy resin.
Ultrathin sections were contrasted with uranyl acetate and
lead citrate. Specimens were examined in a transmission
electron microscope (100CX II, JEOL U.S.A., Peabody,
MA) operated at 80 kV. Samples were also analysed by an
electron dispersive microanalysis system using Quantex
software (Kevex Corp., San Carlos, CA).
ANTIBODIES
The preparation and specificity of polyclonal antibodies
against chicken annexin II and annexin V were described
elsewhere.29 These antibodies do not cross-react with
other annexins and matrix proteins.29 Using extracts from
human cartilage we were able to show that these anti-
bodies react with human annexin II and annexin V, respect-
ively (data not shown). The preparation of polyclonal
antibodies against human type X collagen was described
elsewhere.30 This antibody has been shown to be specific
and does not cross-react with other collagens or matrix
proteins.30 Monoclonal antibodies against human bone and
liver alkaline phosphatase were obtained from Develop-
mental Studies Hybridoma Bank (University of Iowa, Iowa
City, IA) and were described by Lawson et al.31
Results
EMBRYONIC GROWTH PLATE CARTILAGE
In embryonic chick growth plate cartilage cellular stain-
ing for annexin II and V was obtained in prehypertrophic
(PHC), early hypertrophic (EHC) and hypertrophic cartilage
(HC), while in calcified cartilage (CC) both cellular and
matrix staining was detected (Fig. 1A–G). Matrix staining in
calcified cartilage is due to the release of matrix vesicles
containing annexin II and V into the extracellular matrix.3,4
Only a few chondrocytes in the proliferative zone were
positive for annexin II and V, while most of the proliferative
chondrocytes showed no staining (Fig. 1B,E). The cartilage
zones immunostained for annexin II and V corresponded to
those immunostained for type X collagen (data not shown).
NORMAL ARTICULAR CARTILAGE
Four different adult human articular cartilage samples
showing no signs of OA were investigated. Articular carti-
lage can be divided into four zones: the upper zone, middle,
deep and calcified zone. The calcified cartilage zone pro-
vides a transition from the noncalcified deep articular
cartilage zone to the underlying mineralized subchondral
bone. The cartilage samples had a smooth, intact cartilage
surface (Figs 2A,F and 3A,F,K). They were uniformly
stained with safrain O, indicating no loss of proteoglycans,
and with antibodies specific for type II collagen (data not
shown). However, the upper, middle and deep zones of
these specimens did not immunostain with antibodies to
annexin II (AnII, Fig. 2A), annexin V (AnV, Fig. 2F), alkaline
phosphatase (AP, Fig. 3A), and type X collagen (X, Fig. 3F;
see also Table I). Some immunostaining for annexin II,
annexin V, alkaline phosphatase and type X collagen was
detected in areas of calcified cartilage (see Table I), which
is in agreement with previous studies showing that these
molecules are predominantly expressed in hypertrophic
and calcifying cartilage.8,9,32 In addition, treatment of sec-
tions with alizarin red S to detect mineral deposits revealedonly staining in bone and the calcified cartilage zone but not
in the upper, middle and deep zones of normal human
articular cartilage (data not shown).
When sections of normal cartilage samples were treated
with the TUNEL procedure to detect apoptotic cells, none
of the nuclei of the chondrocytes in the upper, middle
(Fig. 3K) and deep zones were stained (see also Table I).
EARLY STAGE OF OSTEOARTHRITIS
Four samples of early stage osteoarthritic cartilage with
a preserved overall thickness of articular cartilage (except
the loss of the 2–3 top layers of elongated cells in some
areas of the upper zone), but loss of proteoglycans in the
upper zone were investigated. Staining of these sections
with antibodies to annexin II (An II, Fig. 2B,C), annexin V
(AnV, Fig. 2G,H) or alkaline phosphatase (AP, Fig. 3B,C)
demonstrated that 60–80% of chondrocytes in the upper
zone were immunopositive for these molecules, while no
staining or only few stained cells were observed in the
deeper zones (see also Table I). Immunostaining forFig. 1. Immunohistochemical analysis of annexin II (AnII, B–D) and
annexin V (AnV, E–G) in sections of 19-day-old embryonic chicken
growth plate cartilage. (A) Schematic representation of the 19-day-
old embryonic chick growth plate; yellow cells represent the resting
chondrocytes (RC), green cells the proliferative chondrocytes
(PC), orange cells the prehypertrophic chondrocytes (PHC), blue
cells the early hypertrophic chondrocytes (EHC), red cells the
hypertrophic chondrocytes (HC) and brown cells the calcified
chondrocytes (CC). (B, E) Immunostaining for annexin II (B) and
annexin V (E) in the zones of proliferative (PC) and pre-
hypertrophic (PHC) chondrocytes. While most of the proliferative
chondrocytes showed no staining for these molecules, cellular
staining was observed in prehypertrophic chondrocytes. (C, F)
Immunostaining for annexin II (C) and V (F) in the zones of early
hypertrophic (EHC) and hypertrophic chondrocytes (HC). Note the
cellular staining for annexin II and V in both zones. (D, G)
Immunostaining for annexin II (D) and V (G) in the hypertrophic
(HC) and calcified zones (CC). While only cellular staining was
obtained in hypertrophic cartilage, cellular and matrix staining was
obtained in calcifying cartilage. Bar, 100 m.
Osteoarthritis and Cartilage Vol. 8 No. 4 297annexin II, annexin V and alkaline phosphatase was mostly
restricted to the cell surface (Figs 2C,H and 3C). In
addition, immunostaining was detected for type X collagen
(X, Fig. 3G,H) in the upper zone of early stage human
osteoarthritic cartilage, but was absent in the deeper
zones.
Labeling of early stage osteoarthritic cartilage sections
with the TUNEL procedure revealed no staining of the
nuclei of chondrocytes throughout the entire cartilage
(Fig. 3L, Table I). Treatment of these samples with alizarin
red S showed no staining of the upper and deeper zones
(data not shown).
LATE STAGE OF OSTEOARTHRITIS
Late stage osteoarthritic cartilage samples (five
samples) showed extensive fissuring, fibrillation, clustering
of cells, and major loss of proteoglycans and cartilage.
Between 70 and 90% of chondrocytes in the upper zone of
late stage human osteoarthritic cartilage showed strong
immunostaining for annexin II (AnII, Fig. 2D,E), annexin V
(AnV, Fig. 2I,J) and alkaline phosphatase (AP, Fig. 3D,E).
Staining was not restricted to the cell surface but was also
found in the pericellular matrix (Figs 2E,J and 3E). Type X
collagen staining was detected in the extracellular matrix
surrounding chondrocytes (Fig. 3I,J). No staining for these
proteins was detected in deeper zones (see Table I).
TUNEL staining of late stage human osteoarthritic
cartilage samples revealed labeling of nuclei of single
chondrocytes and cells in clusters located in the upper
zone, indicating that these cells undergo apoptosis
(Fig. 3M,N). No staining of cells was detected in deeper
zones (data not shown). In some clusters only a few
chondrocytes TUNEL stained (Fig. 3M), while in other
clusters most of the cells were labeled (Fig. 3N).
Treatment of late stage osteoarthritic cartilage samples
with alizarin red S showed staining not only of calcified
cartilage but also of upper areas, while no staining was
detected in deeper zones (Fig. 3O), indicating the formation
of mineral deposits in the upper zone of late stage human
osteoarthritic cartilage.Table I represents a semi-quantitative analysis of the
staining results. The data are presented as the percentage
of total cells, which are immunopositive or TUNEL-positive
in each zone. While normal human articular cartilage
showed no immunostaining for the marker proteins of
terminal differentiation, between 50 and 80% of the cells in
the upper zone of early stage osteoarthritic cartilage
stained for annexin II, annexin V, alkaline phosphatase, and
type X collagen. The percentage of immunopositive cells in
the upper zone slightly increased in late stage osteoarthritic
cartilage. Only between 0 and 10% of cells in the middle
and deep zones of early and late stage osteoarthritic
cartilage showed immunostaining for these proteins. In
contrast, only cells in the upper zone of late stage osteo-
arthritic cartilage were labeled by the TUNEL procedure.
61% of cells in clusters and 60% of cells in areas that
showed no cluster formation were apoptotic.
ELECTRON MICROSCOPIC ANALYSIS OF LATE STAGE HUMAN
OSTEOARTHRITIC CARTILAGE
Electron microscopic analysis of five knee specimens of
late stage human osteoarthritic cartilage revealed mineral
crystals present in the upper zone in all investigated
samples. Matrix vesicles with round shape and various size
were found in the matrix of the upper zone of osteoarthritic
cartilage (Fig. 4A). Matrix vesicles were associated with
calcified areas (Fig. 4B). Electron dispersive X-ray micro-
analysis of these mineralized areas, as seen in Fig. 4B,
revealed strong calcium and phosphate peaks, confirming
that these areas indeed contain calcium phosphate crystals
(Fig. 4C).
Discussion
In this study, we provide evidence that articular chondro-
cytes in the upper zone of human osteoarthritic cartilage
undergo terminal differentiation, release matrix vesicles,
which mineralize the extracellular matrix, and undergo cell
death. In the upper zone of human osteoarthritic cartilageFig. 2. Immunohistochemical analysis of annexin II (AnII, A–E) and annexin V (AnV, F–J) in sections of human normal and osteoarthritic
articular cartilage. (A, F) Note the absence of staining with antibodies against annexin II (A) and annexin V (F) in human normal articular
cartilage from femoral condyle (male, 34 years old). (B, C, G, H) A significant number of chondrocytes in the upper zone of early stage
osteoarthritic cartilage show immunostaining for annexin II (B, C) and annexin V (G, H). (C, H) High magnification showing that staining for
annexin II and V is restricted to the cell. (B, C) femoral condyle, male aged 56 years. (G, H) femoral condyle, female aged 73 years. (D, E,
I, J) Immunostaining for annexin II (D, E) and annexin V (I, J) in the upper zone of late stage osteoarthritic cartilage. (E, J) High magnification
shows that staining for annexin II and V was found not only on the cell surface but also in the surrounding pericellular matrix. (D, E) femoral
condyle, female aged 67 years. (I, J): femoral condyle, female aged 73 years. Bar, 100 m.
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ducing alkaline phosphatase, annexin II, annexin V and
type X collagen were identified. These molecules have
been shown to be normally expressed in hypertrophic and
mineralizing growth plate cartilage (see also Fig. 1).4,8,32,33
The zone of alkaline phosphatase, annexin II, annexin V
and type X collagen expressing chondrocytes in osteo-
arthritic cartilage corresponds to the zone of loss of
proteoglycans. In early stage human osteoarthritic cartilage
between 50 and 80% of chondrocytes of the upper zone
showed immunostaining for these molecules, while in late
stage osteoarthritic cartilage between 70 and 90% of the
cells were immunopositive. Few cells in the deeper zones
showed immunostaining for these molecules. Ultrastruc-
tural analysis revealed matrix vesicles and needle-like
crystals emanating from these particles in the upper zone
of late stage osteoarthritic cartilage. In addition, we found
that ∼60% of cells in upper areas undergo cell death. From
these findings we conclude that chondrocytes in the upper
zone of human osteoarthritic cartilage initiate inappropriate
terminal differentiation, leading to cell death and loss of
structure and function of articular cartilage.
Chondrocytes in the upper zone of human osteoarthritic
cartilage not only activate the expression of molecules
which are predominantly expressed by hypertrophic
chondrocytes, but these cells initiate the mineralization
process. Matrix vesicles are associated with mineralized
areas in upper regions of osteoarthritic cartilage. Matrix
vesicles have a critical role in initiating the mineralization
process in many hard tissues.34 In growth plate cartilage
only terminally differentiated, post-hypertrophic chondro-
cytes release mineralization-competent, alkaline phos-phatase, annexin II, annexin V and type X collagen
containing matrix vesicles, while hypertrophic chondrocytes
release matrix vesicles, which do not contain these com-
ponents, and thus fail to mineralize.4 Our findings here
indicate that chondrocytes in the upper zone of human
osteoarthritic cartilage activate the expression of alkaline
phosphatase, annexin II and V. Interestingly, immunostain-
ing for these proteins is restricted to the cell surface in early
stage of OA, while it is also found in the matrix of late stage
osteoarthritic cartilage. Thus, chondrocytes in the upper
zone of osteoarthritic cartilage release matrix vesicles
which contain alkaline phosphatase, annexin II and V into
the extracellular matrix, and therefore are able to initiate the
mineralization process leading to mineral depositions in
regions where no calcification should occur. Our data are in
agreement with previous findings showing calcium-
phosphate deposition in human osteoarthritic cartilage and
the presence of matrix vesicles with enhanced alkaline
phosphatase activity and the ability to mineralize.35–39
Once mineralization-competent matrix vesicles are
released into the extracellular matrix, they rapidly accumu-
late mineral ions leading to the formation of the first crystal
phase inside the vesicle lumen.34 The annexins (II and V)
are channel forming proteins which enable the rapid influx
of calcium into matrix vesicles.40,41 In addition, annexin V
binds to types II and X collagen thereby anchoring matrix
vesicles to the extracellular matrix, and binding of these
collagens to matrix vesicles stimulates their calcium uptake
and intralumenal crystal growth.42 Crystal deposits in
osteoarthritic cartilage drastically alter its normal physical
properties and impair its function. In addition, crystal
deposition in articular cartilage leads to inflammation,35Fig. 3. Immunostaining for alkaline phosphatase (AP, A–E), type X collagen (X, F–J), TUNEL staining (K–N) and alizarin red S staining (O)
of sections of human normal and osteoarthritic cartilage. Note the absence of immunostaining for alkaline phosphatase (A) and type X
collagen (F) in normal human articular cartilage, while staining for alkaline phosphatase (B–E) and type X collagen (G–J) was detected in
the upper zone of early stage and late stage human osteoarthritic cartilage. (A, B, D, F, G, I) Low magnification; (C, E, H, J) High
magnification. (A, F) femoral condyle, male aged 34 years; (B, C) femoral condyle, male aged 56 years; (G, H) femoral condyle, female aged
70 years; (D, E) tibial plateau, female aged 69 years; (I, J) femoral condyle, male aged 79 years. (K–N) TUNEL staining revealed no labeling
of chondrocytes in normal (K) and early stage osteoarthritic (L) cartilage, but note the presence of TUNEL positive cells in the upper zone
of late stage osteoarthritic cartilage (M, N). In some cell clusters only a few chondrocytes were stained (M, arrow), while in other clusters
most of cells were TUNEL positive (N). (O) Alizarin red S staining of late stage osteoarthritic cartilage. Note the staining not only in calcified
cartilage (CC) but also in the upper zone (arrows). (K) tibial plateau, male aged 59 years; (L) femoral condyle, female aged 73 years;
(M, N) femoral condyle, female aged 73 years; (O) tibial plateau, female aged 69 years; Bar, 100 m.
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production in chondrocytes,43 thereby accelerating carti-
lage destruction. We have evidence that the 1,4-
benzothiazepine derivative K-201, a compound that
selectively blocks annexin channel activities,44,45 inhibits
calcium uptake and mineralization of matrix vesicles (T.
Kirsch et al., submitted). Thus, the interference with
annexin channel activities might prevent crystal deposition
in osteoarthritic cartilage.
As shown in this study, chondrocytes in the upper zone
of osteoarthritic cartilage undergo a series of differentiationevents, eventually leading to cell death or apoptosis. These
results are supported by previous studies demonstrating
apoptotic cells in upper layers of osteoarthritic human and
rabbit cartilage.37,46,47 Programmed cell death or apoptosis
was also found in mineralizing growth plate chondrocytes
close to the chondro-osseous junction.2,48 Our findings
would explain why articular chondrocytes in the upper zone
of human osteoarthritic cartilage fail to repair the extra-
cellular matrix. These cells lose their stable phenotype,
undergo terminal differentiation and eventually cell death.
They also, instead of synthesizing a type II collagen- andFig. 4. Electron microscopy of late stage human osteoarthritic cartilage. (A) Electron micrograph showing matrix vesicles (MV) in the matrix
of the upper zone. (B) Mineralized areas (MA) in upper regions of late stage osteoarthritic cartilage. Note that matrix vesicles (arrows) are
associated with crystal deposits. (C) Energy dispersive X-ray microanalysis of mineralized areas as shown in (B). Note the presence of
calcium (Ca) and phosphate (P) peaks. Tibial plateau, male aged 70 years (×72500).Table I
Percentage of cells in the upper, middle, deep and calcified zones of normal articular cartilage, early and late stage osteoarthritic cartilage
showing immunostaining for annexin II, annexin V, alkaline phosphatase (APase), type X collagen, or TUNEL labeling
Surface zone Middle zone Deep zone Calcified zone
Annexin II
Normal 0 0 0 58.1±5.9
Moderate 80.3±4.9 3.5±1.6 3.3±1.9 39.5±13.2
Severe 88.8±2.5 6.3±5.3 4.6±2.5 63.1±1.9
Annexin V
Normal 0 0 0 29.4±8.5
Moderate 70.0±16.6 5.3±0.5 1.5±2.1 21.4±4.3
Severe 69.8±12.8 4.1±1.1 5.0±6.7 24.3±1.5
APase
Normal 0 0 0 57.9±5.6
Moderate 63.2±6.3 0 0 57.7±12.4
Severe 75.2±4.1 4.3±1.4 1.7±0.4 60.8±7.4
Type X
Normal 0 0 3.8±2.1 80.4±4.5
Moderate 49.8±6.2 5.2±2.3 7.1±3.2 73.2±3.2
Severe 78.5±7.6 3.8±1.8 9.9±4.1 73.8±1.0
Apoptosis Single cells Clusters Single cells Clusters Single cells Clusters Single cells Clusters
Normal 0 0 0 0 0 0 0 0
Moderate 0 0 0 0 0 0 0 0
Severe 60.3±3.6 61.3±6.2 0 0 0 0 0 0
Mineralization
Normal No No No Yes
Moderate No No No Yes
Severe Yes No No Yes
200–300 chondrocytes in upper, middle, deep and calcified zones of normal articular cartilage, early and late stage osteoarthritic cartilage
from four different donors were counted as described in Methods. Data are expressed as the mean±SD of the percentage of total cells which
show cell-associated staining. For apoptosis, TUNEL-positive single cells and cells in clusters were counted separately.
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articular cartilage, produce a type X collagen-rich, mineral-
izing matrix similar to the matrix found in hyper-
trophic and calcifying cartilage during endochondral
ossification.4,49–52
Terminal differentiation of growth plate chondrocytes is
controlled by a variety of factors. For example, we and
others have shown that differentiation of hypertrophic
chondrocytes to terminally differentiated, post-hypertrophic
mineralizing chondrocytes requires cues, such as vitamin A
or C.4,41,50,52,53 On the other hand growth factors, such as
FGF, PTHrP and TGF, were shown to inhibit maturation of
chondrocytes.54–59 Human articular chondrocytes of the
upper zone initiate alkaline phosphatase and type X colla-
gen synthesis when cultured in suspension in the presence
of fetal calf serum, suggesting that these cells are arrested
in an early stage of differentiation, but upon receiving the
appropriate stimuli then can undergo terminal differen-
tiation.60 Interestingly, it has been demonstrated that
conditioned media from immature chondrocyte cultures
prevent hypertrophy, and that this effect is abolished by
addition of monoclonal antibodies to TGF.58 In addition, a
previous study has indicated that the loss of responsive-
ness to TGF promotes terminal differentiation of chondro-
cytes and results in the development of joint diseases, such
as OA.59 Thus, it can be speculated that human articular
chondrocytes physiologically synthesize factors, such as
TGF, which inhibit their terminal differentiation. During
pathogenesis, however, articular chondrocytes in the upper
zone stop producing these factors leading to terminal
differentiation, cell death, and cartilage destruction. In
addition, osteoarthritic chondrocytes are exposed to growth
factors synthesized by synovial cells and released into
the joint cavity, which might further promote terminal
differentiation of these cells.
In conclusion, our study provides evidence that terminal
differentiation is the main fate of chondrocytes in the upper
zone of human osteoarthritic cartilage. These cells re-
semble a phenotype similar to terminally differentiated,
post-hypertrophic mineralizing chondrocytes of the epiphy-
seal growth plate. They activate the expression of alkaline
phosphatase, annexin II, annexin V, type X collagen, and
the release of matrix vesicles, components which play
major roles in the initiation of mineralization.8,41,42 The
inappropriate terminal differentiation of articular chondro-
cytes in OA not only leads to cell death and failure of tissue
repair, but is also accompanied by the deposition of
hydroxyapatite crystals. Crystal deposition in articular car-
tilage can lead to inflammation and stimulation of metallo-
protease production,35 which could positively feedback or
accelerate terminal differentiation of articular chondrocytes
and cartilage destruction. Thus, prevention of terminal
differentiation and matrix mineralization in human osteo-
arthritic cartilage might be a novel therapeutic target
in OA.
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